Create Content

Working locally, collaborating globally

 IPCRG's report to the Commonwealth Health Minister's asks them to invest in

1. Solutions that reduce women and children's exposure to indoor smoke
2. Production of real-life evidence that feeds into guidelines
3. Right incentives for primary care to support patients to stop smoking
4. Universal access to good quality inhaled medicines for asthma and training in how to use them
5. Integrated care involving patients, multi-disciplinary health and social care
6. Practical training and education for primary care led by peers
7. Compact, pragmatic NGOs such as the IPCRG that can leverage major clinician-led change

To read more about the meeting in May click here and to download the book click here

IPCRG Position Paper - Primary care and chronic lung disease

The World Health Organization (WHO) estimates that better use of primary health care principles and approaches and better access is the only way to cope with today’s global disease burden. This IPCRG Position Paper summarises the potential positive impact of primary care
on two of the major contributors to the global disease burden (tobacco
dependence and chronic lung disease) and describes how it could reduce variation in access to care and health outcomes.

Our position paper was launched during our workshop: Allergy and Asthma in GP's practice at the Prevention and control of childhood asthma and allergy in the EU from the public health point of view: urgent need to fill the gaps meeting in Poland 21 - 22 September 2011.


Chronic diseases and development - the Lancet series in advance of the UN Summit includes recent publication: Priority actions for the non-communicable disease crisis

World Health Organization Chronic diseases


World Health Organisation Europe

World Health Organisation Europe Health Evidence Network (HEN)
How can chronic disease management programmes operate across care settings and providers?

Available in:

This recent review of the impact of asthma and COPD in sub-Saharan Africa (published in the Primary Care Respiratory Journal was circulated by GARD in June 2011.  Full text is available in pdf.

Key message

  1. Chronic diseases affect all countries, and the increase in their prevalence is largely attributable to changing demographics, increased life expectancy, changing lifestyles, better disease management and treatment and a better understanding of the factors that cause poor health and disease.

  2. In the WHO European Region, 86% of deaths are attributable to chronic diseases. With 50–80% of all global health spending related to chronic diseases, health systems that maintain current disease management practices cannot afford to continue caring for the escalating numbers of people with chronic diseases.

  3. Chronic disease management is a systematic approach to coordinating health care interventions across levels (individual, organizational, local and national), and good evidence indicates that such coordination across care settings and providers is more effective than single or uncoordinated interventions.

  4. Policy options to manage chronic diseases can be pursued via different avenues but can be broadly divided into individual, health delivery systems and system-wide approaches. Interventions in European countries generally focus on specific diseases rather than determinants and are often insufficiently coordinated.

  5. Interventions such as ranking people according to their risk, multidisciplinary teams and supporting self-management have potential but only if policies, structures and financial and other incentives support people in working together.

  6. There is no correct approach to chronic disease management. Evidence throughout the world suggests that, to be successful, policy-makers should consider:
    • providing strong leadership and vision at the national, regional or organizational level;
    • ensuring robust collection of information and data-sharing among all stakeholders;
    • providing care based on people’s needs and an ability to identify people with different levels of need;
    • targeting key risk factors, including widespread disease prevention initiatives;
    • supporting self-management and empowering people with chronic diseases; and
    • involving a wide range of stakeholders such as individuals, the voluntary and community sector, clinicians, private industry and public services.




  • No labels